{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP01130",
    "Peptide Name": "PGLa-AM1 (natural AMPs; frog, amphibians, animals; Ala-rich; UCLL1c; XXA; BBL; PGLa-AM2: inactive, MIC >200 uM)",
    "Source": "skin secretions, the octoploid frog,Xenopus amieti(Pipidae), Africa",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GMASKAGSVLGKVAKVALKAAL",
    "Sequence Length": 22,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "anti-diabetes",
      "anti-sepsis"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": -0.63,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "59%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Active against E. coli (25 uM) and S. aureus (MIC 50 uM). Beta-cells without cytotoxicity at concentrations up to 3 uM. The peptide can bind to LPS (McLean et al., 2014). It has the potential to be developed into molecules that treat patients with Type 2 diabetes (T2D) (Owolabi BO et al., 2017). Updated 4/2017; 5/2019; 7/2020.",
    "Author": "Conlon JM, Al-Ghaferi N, Ahmed E, Meetani MA, Leprince J, Nielsen PF.2010",
    "Reference": "Peptides. 2010 Jun;31(6):989-94.",
    "Title": "Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae)."
  },
  "3D Structure": []
}